Patents by Inventor Bruno Robert

Bruno Robert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230002497
    Abstract: Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality worldwide. Acute exacerbation of COPD (AE-COPD) in patients are mostly due to respiratory infection and are associated with an inexorable decline in lung function, enhanced oedema as well as airway and systemic inflammation. Previous results show that treatment with anti-IL-20Rb blocking antibodies increased the bacterial clearance in control mice infected by S. pneumoniae and protected CS-exposed mice from bacterial infection, by decreasing the bacterial burden and the inflammatory infiltrate. Therefore there is an interest for generating monoclonal antibodies specific for IL-20Rb with a neutralizing activity for their use in the treatment of AE-COPD. The present invention fulfills this need by providing antibodies having specificity for IL-20Rb.
    Type: Application
    Filed: September 3, 2020
    Publication date: January 5, 2023
    Inventors: Philippe GOSSET, Muriel PICHAVANT, Pierre MARTINEAU, Myriam CHENTOUF, Bruno ROBERT, Mélina LE ROUX
  • Publication number: 20220349466
    Abstract: Oil system for a turbomachine, making it possible to continue the supply of oil to the pieces of equipment of the turbomachine in case of occurrence of a fire within the turbomachine, including an oil circuit, at least one oil-consuming piece of equipment, supplied by the oil circuit, a pumping unit, including at least one speed-pilotable electrically driven pump, supplying the oil circuit, and an electronic control unit, configured to pilot the electrically driven pump, wherein the electronic control unit includes two separate logics of piloting the electrically driven pump, and wherein the electronic control unit is configured to pilot the electrically driven pump according to the first logic by default and to switch to the second logic in case of receipt of a signal representative of the presence of a fire or of an overheating.
    Type: Application
    Filed: May 4, 2020
    Publication date: November 3, 2022
    Applicant: SAFRAN AIRCRAFT ENGINES
    Inventors: Bruno Robert GAULLY, Germain Michel Emmanuel BERTHO, Yves EMPRIN
  • Publication number: 20220324962
    Abstract: In ovarian carcinoma, Müllerian Inhibiting Substance (MIS) type II receptor (MISRII) and the MIS/MISRII signaling pathway are potential therapeutic targets. Conversely, the role of the three MIS type I receptors (MISRI; ALK2, ALK3 and ALK6) in this cancer needs to be clarified. Using four ovarian cancer cell lines and ovarian cancer cells isolated from patients' tumor ascites, the inventors found that ALK2 and ALK3 are the two main MISRIs involved in MIS signaling at low and high MIS concentrations, respectively. Moreover, high MIS concentrations were associated with apoptosis and decreased clonogenic survival, whereas low MIS concentrations improved cancer cell viability. Finally, the inventors showed that anti-MIS antibody B10 inhibited MIS pro-survival effect. These last results open the way to an innovative therapeutic approach to suppress MIS proliferative effect, instead of administering high doses of MIS to induce cancer cell apoptosis.
    Type: Application
    Filed: September 25, 2020
    Publication date: October 13, 2022
    Inventors: André PELEGRIN, Bruno ROBERT, Pierre MARTINEAU, Maëva CHAUVIN, Myriam CHENTOUF, Nathalie DI CLEMENTE-BESSE
  • Patent number: 11186635
    Abstract: The present invention relates to monoclonal antibodies that bind to the CD160-TM isoform. The inventors developed new monoclonal antibodies which bind to the CD160-TM isoform but dot not bind to the CD160 GPI-anchored isoform not to the CD160 soluble isoform. In particular, the antibodies of the present invention are suitable for amplifying NK cell activation and therefore cytotoxic functions NK cells.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: November 30, 2021
    Inventors: Armand Bensussan, Bruno Robert, Pierre Martineau, Myriam Chentouf, Anne Marie-Cardine, Jérôme Giustiniani
  • Publication number: 20210188983
    Abstract: The present invention relates to polypeptides for preparing drug conjugates capable of promoting apoptosis in a cell expressing an orexin receptor. In particular, the present invention relates to a polypeptide comprising the amino acid sequence of formula of X20-X21-X22-X23-G-X25-L-X27-X28 wherein: —X20 represents N, D, or K, —X21 represents H, A or Q, —X22 represents A, S, T or G, —X23 represents A, T or G, —X25 represents I or L, —X27 represents T or V and, —X28 represents M, L, V, Y or I.
    Type: Application
    Filed: February 17, 2017
    Publication date: June 24, 2021
    Inventors: Bruno ROBERT, Pierre MARTINEAU, Alain COUVINEAU
  • Patent number: 10758615
    Abstract: The present disclosure relates to human monoclonal antibodies against orexin receptor type 1 (OX1R, hyprocretin 1) and uses thereof for the treatment of cancer. The antibodies are characterized by their CDRs: NYYMN, YISGSSRNIYYADFVKG, SNYDGMDV (Heavy chain) and AGTSSDVGGSNYVS, PGKAP, SSYTYYSTRV (Light Chain)) or the CDRS having at least 50% or 70% identity with the above listed sequences.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: September 1, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS DIDEROT—PARIS 7, INSTITUT REGIONAL DU CANCER DE MONTPELLIER, UNIVERSITE DE MONTPELLIER
    Inventors: Alain Couvineau, Thierry Voisin, Pascal Nicole, Bruno Robert, Pierre Martineau, Myriam Chentouf
  • Patent number: 10578030
    Abstract: A method of adjusting a fuel flow rate in a turbine engine propelling an aircraft, including: obtaining a first estimate of a flow rate of fuel injected into a combustion chamber of the turbine engine propelling an aircraft and as delivered by a fuel metering device of the turbine engine; obtaining a second estimate of the fuel flow rate, which second estimate is more accurate than the first estimate for at least one range of fuel flow rate values and being delivered by an estimator device having a flow meter; and adjusting the fuel flow rate threshold value with help of a difference evaluated between the first estimate and the second estimate, the threshold value being for use in an open loop for regulating the turbine engine.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: March 3, 2020
    Assignee: SAFRAN AIRCRAFT ENGINES
    Inventors: Christophe Javelot, Cedrik Djelassi, Bruno Robert Gaully, Ismail Sylla
  • Patent number: 10571316
    Abstract: A method and a device for determining, in real time, the flow rate of air collected from an aircraft engine by a system for collecting air from the engine, including an acquisition device for acquiring at successive times measurements of physical quantities in respect of temperature, pressure and pressure loss, specific for the air collection system, a computing device for evaluating at each current time of the successive times a first current estimation of the flow rate of air collected from the aircraft engine on the basis of the physical quantity measurements, the acquisition device for acquiring at the current time a minimum current air flow rate data item defined on the basis of a predetermined flow rate tables, the computing device for hybridising, at the current time, the first current air flow rate estimation and the minimum current air flow rate data item to form a second current air flow rate estimation.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: February 25, 2020
    Assignee: SAFRAN AIRCRAFT ENGINES
    Inventors: Bruno Robert Gaully, Vincent Cabret, Amaury Olivier, Jerome Guy Roger Sebaa
  • Patent number: 10527837
    Abstract: Method for obtaining an super-resolution image (22) of an object (5), based upon an optical microscope (21) including a support plate (6) for bearing the object, an illumination source (1) for focusing an illumination beam (14) onto a target region of the support plate, a digital camera (9) including a matrix of sensors, comprising: capturing, by the digital camera, a first image of the target region; extracting, from the first image, a first block of pixel values provided by a sub-matrix (B0) of the matrix of sensors; displacing, by a sub-diffraction limited distance, the support plate by the displacement block along a displacement axis; capturing, by the digital camera, a second image of the target region; extracting, from the second image, a second block of pixel values provided by the sub-matrix (B0) of the matrix of sensors; storing said first and second blocks of pixel values as a first and second blocks of pixel values to be placed right next each other in the super-resolution image along the image axi
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: January 7, 2020
    Assignees: COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Bruno Robert, Andrew Gall, Dmitrij Frolov, Rienk Van Grondelle
  • Patent number: 10398774
    Abstract: The present disclosure provides human monoclonal antibodies and antibody-drug conjugates against AXL and their use for the treatment of cancer.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: September 3, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITE DE MONTPELLIER, INSTITUT REGIONAL DU CANCER DE MONTPELLIER
    Inventors: Bruno Robert, Christel Larbouret, Pierre Martineau, Marie-Alix Poul
  • Publication number: 20190256595
    Abstract: The present invention relates to monoclonal antibodies that bind to the CD160-TM isoform. The inventors developed new monoclonal antibodies which bind to the CD160-TM isoform but dot not bind to the CD160 GPI-anchored isoform not to the CD160 soluble isoform. In particular, the antibodies of the present invention are suitable for amplifying NK cell activation and therefore cytotoxic functions NK cells.
    Type: Application
    Filed: October 25, 2017
    Publication date: August 22, 2019
    Inventors: Armand BENSUSSAN, Bruno ROBERT, Pierre MARTINEAU, Myriam CHENTOUF, Anne MARIE-CARDINE, Jérôme GIUSTINIANI
  • Publication number: 20180280549
    Abstract: Disclosed are methods for diagnosing pancreatic cancer, including measuring the expression level of ASCT1 and/or ASCT2 and/or XPR1. Also disclosed is a RBD ligand coupled to at least one contrast agent, that may be used as a probe for medical imaging.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 4, 2018
    Applicants: METAFORA BIOSYSTEMS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE MONTPELLIER, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
    Inventors: Jawida TOUHAMI, Guangqi E, Donatella GIOVANNINI, Bruno ROBERT, Samuel SEVESTRE, Muriel BUSSON, Jean-Luc BATTINI, Vincent PETIT, Marc SITBON
  • Patent number: 9903277
    Abstract: The invention relates to a method for monitoring the operation of a fuel circuit shut-off valve comprising an LPSOV, a flow regulator, the shut-off valve, characterised in that it comprises: a step for ordering (30) the closure of the valves; a step for measuring (32) the fuel flow rate in the circuit qui carried out before the LPSOV is completely closed; and a diagnostic step (34) consisting of determining that said shut-off valve is defective if the fuel flow rate measured is not equal to zero and determining that said shut-off valve is operating correctly if the fuel flow rate measured is zero.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: February 27, 2018
    Assignee: SNECMA
    Inventors: Brice Andre, Virginie Ayrault, Bruno Robert Gaully
  • Publication number: 20180030135
    Abstract: The present disclosure relates to human monoclonal antibodies against orexin receptor type 1 (OX1R, hyprocretin 1) and uses thereof for the treatment of cancer. The antibodies are characterized by their CDRs: NYYMN, YISGSSRNIYYADFVKG, SNYDGMDV (Heavy chain) and AGTSSDVGGSNYVS, PGKAP, SSYTYYSTRV (Light Chain)) or the CDRS having at least 50% or 70% identity with the above listed sequences.
    Type: Application
    Filed: January 14, 2016
    Publication date: February 1, 2018
    Inventors: Alain COUVINEAU, Thierry VOISIN, Bruno ROBERT, Pascal NICOLE, Myriam CHENTOUF, Pierre MARTINEAU
  • Publication number: 20180002421
    Abstract: The present disclosure relates to human monoclonal antibodies against orexin receptor type 1 (OX1R, hyprocretin 1) and uses thereof for the treatment of cancer. The antibodies are characterized by their CDRs: NYYMN, YISGSSRNIYYADFVKG, SNYDGMDV (Heavy chain) and AGTSSDVGGSNYVS, PGKAP, SSYTYYSTRV (Light Chain)) or the CDRS having at least 50% or 70% identity with the above listed sequences.
    Type: Application
    Filed: January 14, 2016
    Publication date: January 4, 2018
    Inventors: Alain COUVINEAU, Thierry VOISIN, Pascal NICOLE, Bruno ROBERT, Pierre MARTINEAU, Myriam CHENTOUF
  • Publication number: 20170351080
    Abstract: Method for obtaining an super-resolution image (22) of an object (5), based upon an optical microscope (21) including a support plate (6) for bearing the object, an illumination source (1) for focusing an illumination beam (14) onto a target region of the support plate, a digital camera (9) including a matrix of sensors, comprising: capturing, by the digital camera, a first image of the target region; extracting, from the first image, a first block of pixel values provided by a sub-matrix (B0) of the matrix of sensors; displacing, by a sub-diffraction limited distance, the support plate by the displacement block along a displacement axis; capturing, by the digital camera, a second image of the target region; extracting, from the second image, a second block of pixel values provided by the sub-matrix (B0) of the matrix of sensors; storing said first and second blocks of pixel values as a first and second blocks of pixel values to be placed right next each other in the super-resolution image along the image axi
    Type: Application
    Filed: December 23, 2015
    Publication date: December 7, 2017
    Inventors: Bruno ROBERT, Andrew GALL, Dmitrij FROLOV, Rienk VAN GRONDELLE
  • Publication number: 20170340734
    Abstract: The present disclosure provides human monoclonal antibodies and antibody-drug conjugates against AXL and their use for the treatment of cancer.
    Type: Application
    Filed: December 8, 2015
    Publication date: November 30, 2017
    Inventors: Bruno ROBERT, Christel LARBOURET, Pierre MARTINEAU, Marie-Alix POUL
  • Patent number: 9821736
    Abstract: A device for ventilating and electrically powering a computer of an engine of an aircraft, the device including a feed mechanism feeding air to a proximity of the computer and a fan connected to a drive mechanism and configured to generate a stream of air for ventilating the computer. The fan is mounted in the air feed mechanism, and the drive mechanism includes an electrical machine configured to operate as a motor for driving the fan, and as a generator for powering the computer, a rotor of the machine when operating as a generator being driven by the fan, which is itself driven by a stream of air flowing in or leaving the air feed mechanism.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: November 21, 2017
    Assignee: SNECMA
    Inventors: Thomas Lepage, Bruno Robert Gaully
  • Patent number: 9809654
    Abstract: The invention is directed to a compound comprising one or more CD1d complexes in association with an antibody specific for a cell surface marker. The CD1d complexes comprise a CD1d, a ?2-microglobulin molecule, and may further comprise an antigen bound to the CD1d binding groove. The invention is further directed to methods of inhibiting or stimulating an immune response with the CD1d-antibody compounds, in particular anti-tumor and autoimmunity responses.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: November 7, 2017
    Assignee: Vaccinex, Inc.
    Inventors: Bruno Robert, Alena Donda, Valerie Cesson, Jean-Pierre Mach, Maurice Zauderer
  • Patent number: D990661
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: June 27, 2023
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Silas Sao Jin Siew, Vitaly Kapelevich, Janine Elizabeth Collins, Steve Thomas, Lydia Kathleen McGlashan, Mark Andrew Thompson, Jordan Dean Jones Kimpton, Bruno Sintive, Roshalee Nundloll, Yunhe Guan, Paul Mathew Freestone, Bruce Michael Walls, Jake Baker Hocking, Chris Onin Limpin Hipolito, Katie O'Brien, Arvin San Jose Gardiola, Matthew Robert Geoff Slight, Christopher Gareth Sims, Blair Raymund Dadson Murphy